Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | SYK | P43405 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | AHR | P35869 | 1/20 | 0.40 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | METAP2 | P50579 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4615654 | 0.85 | KDM4E (0.52) | KDM4EALDH1A1RAB9AMAPTSMN1; SMN2 | |
| SCHEMBL1122415 | 0.82 | PARP1 (0.46) | PARP1KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL17714447 | 0.80 | L3MBTL1 (0.50) | KDM4EALDH1A1HSD17B10TDP1 | |
| SCHEMBL497429 | 0.79 | PARP1 (0.53) | PARP1KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL1937751 | 0.79 | PARP1 (0.53) | PARP1KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL5196284 | 0.79 | PARP1 (0.53) | PARP1KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL28805611 | 0.79 | KDM4E (0.38) | PARP1KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL29900286 | 0.78 | ALDH1A1 (0.35) | KDM4EALDH1A1HSD17B10RAB9AMAPT | |
| SCHEMBL31439135 | 0.77 | PARP1 (0.51) | PARP1KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL353231 | 0.77 | KDM4E (0.55) | PARP1KDM4EALDH1A1HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023110772-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING AT LEAST A MEROCYANINE AND A HYDROTROPE | L'OREAL (FR) | 2023-06-22 | — | — | WO | claimed |
| CN-109414382-A | Containing 4- (3- ethyoxyl -4- hydroxyphenyl) butyl- 2- ketone, nicotinamide compounds liquid mixture and contain the cosmetic composition of the liquid mixture | 莱雅公司 | 2019-03-01 | — | — | CN | claimed |
| EP-3362436-A1 | PROCESS FOR THE CATALYTIC DIRECTED CLEAVAGE OF AMIDE-CONTAINING COMPOUNDS | Universiteit Antwerpen (BE) | 2018-08-22 | — | — | EP | claimed |
| WO-2017046133-A1 | PROCESS FOR THE CATALYTIC DIRECTED CLEAVAGE OF AMIDE-CONTAINING COMPOUNDS | UNIVERSITEIT ANTWERPEN (BE) | 2017-03-23 | — | — | WO | claimed |
| WO-2002030466-A2 | PHARMACEUTICAL APPLICATIONS OF HYDROTROPIC AGENTS, POLYMERS THEREOF, AND HYDROGELS THEREOF | PURDUE RESEARCH FOUNDATION (US) | 2002-04-18 | — | — | WO | claimed |
| US-4204065-A | Soft quaternary surface active agents and method of using same | INTERX RESEARCH CORPORATION (US) | 1980-05-20 | — | — | US | claimed |
| WO-2024028512-A1 | COMPOSITIONS COMPRISING AN ANTIMICROBIAL BOOSTING AGENT | SYMRISE AG (DE) | 2024-02-08 | — | — | WO | disclosed |
| WO-2023110763-A1 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION COMPRISING AT LEAST ONE MEROCYANINE AND AT LEAST ASCORBIC ACID AND/OR A DERIVATIVE THEREOF | L'OREAL (FR) | 2023-06-22 | — | — | WO | disclosed |
| WO-2023110772-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING AT LEAST A MEROCYANINE AND A HYDROTROPE | L'OREAL (FR) | 2023-06-22 | — | — | WO | disclosed |
| WO-2023104924-A1 | COMPOSITION COMPRISING A COMBINATION OF POLYGLYCEROL ESTERS AND A FILLER | L'OREAL (FR) | 2023-06-15 | — | — | WO | disclosed |
| WO-2021125708-A1 | NICOTINAMIDE RIBOSIDE DERIVATIVE CONJUGATED TO FATTY AMINE | 주식회사 휴메딕스 | 2021-06-24 | — | — | WO | disclosed |
| CN-110446487-A | Contain the composition with the phenolic compound for cooperateing with anti-oxidant benefit | OREAL | 2019-11-12 | — | — | CN | disclosed |
| CN-109689012-A | Photostable compositions and methods of use | 莱雅公司 | 2019-04-26 | — | — | CN | disclosed |
| CN-105473126-B | For cosmetic use containing there are two types of the compositions of phenolic compound | 莱雅公司 | 2019-04-09 | — | — | CN | disclosed |
| CN-101384544-B | Substituted cyclohexylmethyl derivatives | GRUENENTHAL GMBH | 2014-01-22 | — | — | CN | disclosed |
| US-20030031715-A1 | Pharmaceutical applications of hydrotropic agents, polymers thereof, and hydrogels thereof | PURDUE RESEARCH FOUNDATION | 2003-02-13 | — | — | US | disclosed |
| WO-2002030466-A2 | PHARMACEUTICAL APPLICATIONS OF HYDROTROPIC AGENTS, POLYMERS THEREOF, AND HYDROGELS THEREOF | PURDUE RESEARCH FOUNDATION (US) | 2002-04-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030031715-A1 | Pharmaceutical applications of hydrotropic agents, polymers thereof, and hydrogels thereof | HMGB2, HTT, ABCG2 | PARP1 912/4885KDM4E 4850/4885ALDH1A1 3603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.